About a third of heart disease patients undergoing angioplasty to open up blocked arteries develop complications and even new blockages caused by stents-the tiny metal scaffolds inserted to hold the arteries open. Now researchers at the Children’s Hospital of Philadelphia have developed a way to shield arteries from such complications using the stents themselves to deliver beneficial genes to the body. In contrast to other methods of gene therapy, which use viruses as carriers, this new approach depends on coating the stents with a biodegradable polymer containing therapeutic genes. In recent experiments, researchers inserted the coated stents into pigs’ arteries and observed the polymer degrade, releasing genes into the arterial-wall cells. Once inside the cells, the genes began producing specific proteins. According to head researcher Robert Levy, the team is screening various candidate genes to find one that would not only protect blood vessels but also treat underlying heart disease. They hope to start human clinical trials within three years.
This startup wants to copy you into an embryo for organ harvesting
With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics.
This artist is dominating AI-generated art. And he’s not happy about it.
Greg Rutkowski is a more popular prompt than Picasso.
VR is as good as psychedelics at helping people reach transcendence
On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms.
This nanoparticle could be the key to a universal covid vaccine
Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.